Patents by Inventor Simon Goepfert
Simon Goepfert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11976286Abstract: A plant cell comprising: (a) a polynucleotide sequence encoding a nitrate reductase polypeptide comprising a contiguous polypeptide sequence of SEQ ID NO: 5 or SEQ ID NO: 7, wherein methionine is substituted for an amino acid that reduces nitrate reductase activity in the plant cell as compared to a control plant cell; (b) a polypeptide sequence encoded by the polynucleotide sequence set forth in (a); or (c) a construct, vector or expression vector comprising the polynucleotide sequence set forth in (b).Type: GrantFiled: December 16, 2019Date of Patent: May 7, 2024Assignee: Philip Morris Products S.A.Inventors: Lucien Bovet, Prisca Campanoni, Simon Goepfert
-
Publication number: 20230397649Abstract: An aerosol-generating substrate for a heated aerosol-generating article is provided, the aerosol-generating substrate including: homogenised tobacco material, the homogenised tobacco material including dried green tobacco material, an aerosol former, and a binder, the homogenised tobacco material having an aerosol former content of between 5 percent and 55 percent by weight on a dry weight basis. A dried green tobacco material for forming an aerosol-generating substrate for an aerosol-generating article, and a method of producing dried green tobacco material for the aerosol-generating substrate, are also provided.Type: ApplicationFiled: October 29, 2021Publication date: December 14, 2023Applicant: Philip Morris Products S.A.Inventors: Lucien BOVET, Simon GOEPFERT, Aurore HILFIKER, Delphine LANGLET
-
Patent number: 11685929Abstract: There is described herein a mutant, non-naturally occurring or transgenic plant or part thereof having reduced expression of the gene encoding Terminal Flower 1 (TFL1) or reduced activity of the protein encoded by TFL1, said TFL1 comprising, consisting or consisting essentially of (i) a polynucleotide sequence comprising, consisting or consisting essentially of a sequence having at least 72% sequence identity to SEQ ID NO:7 or SEQ ID NO:8 or SEQ ID NO:10 or SEQ ID NO:11 or SEQ ID NO:19 or SEQ ID NO:20; or (ii) a polypeptide encoded by the polynucleotide set forth in (i); or (iii) a polypeptide having at least 72% sequence identity to SEQ ID NO:9 or SEQ ID NO:12 or SEQ ID NO:21; wherein the expression or activity of the polynucleotide or the polypeptide set forth in (i), (ii) or (iii) is reduced as compared to a control plant in which the expression or activity of the polynucleotide or the polypeptide set forth in (i), (ii) or (iii) has not been reduced.Type: GrantFiled: December 15, 2017Date of Patent: June 27, 2023Assignee: Philip Morris Products S.A.Inventors: Lucien Bovet, Simon Goepfert, Helene Laparra
-
Publication number: 20220186242Abstract: A plant cell comprising: (a) a polynucleotide sequence encoding a nitrate reductase polypeptide comprising a contiguous polypeptide sequence of SEQ ID NO: 5 or SEQ ID NO: 7, wherein methionine is substituted for an amino acid that reduces nitrate reductase activity in the plant cell as compared to a control plant cell; (b) a polypeptide sequence encoded by the polynucleotide sequence set forth in (a); or (c) a construct, vector or expression vector comprising the polynucleotide sequence set forth in (b).Type: ApplicationFiled: December 16, 2019Publication date: June 16, 2022Inventors: Lucien Bovet, Prisca Campanoni, Simon Goepfert
-
Publication number: 20200208164Abstract: There is described herein a mutant, non-naturally occurring or transgenic plant or part thereof having reduced expression of the gene encoding Terminal Flower 1 (TFL1) or reduced activity of the protein encoded by TFL1, said TFL1 comprising, consisting or consisting essentially of (i) a polynucleotide sequence comprising, consisting or consisting essentially of a sequence having at least 72% sequence identity to SEQ ID NO:7 or SEQ ID NO:8 or SEQ ID NO:10 or SEQ ID NO:11 or SEQ ID NO:19 or SEQ ID NO:20; or (ii) a polypeptide encoded by the polynucleotide set forth in (i); or (iii) a polypeptide having at least 72% sequence identity to SEQ ID NO:9 or SEQ ID NO:12 or SEQ ID NO:21; wherein the expression or activity of the polynucleotide or the polypeptide set forth in (i), (ii) or (iii) is reduced as compared to a control plant in which the expression or activity of the polynucleotide or the polypeptide set forth in (i), (ii) or (iii) has not been reduced.Type: ApplicationFiled: December 15, 2017Publication date: July 2, 2020Inventors: Lucien Bovet, Simon Goepfert, Helene Laparra
-
Patent number: 10415050Abstract: The present invention relates to a mutant, non-naturally occurring or transgenic tobacco plant cell comprising: (i) a polynucleotide comprising, consisting or consisting essentially of a sequence encoding a functional nicotine N-demethylase and having at least 95% sequence identity to SEQ ID NO:2; (ii) a polypeptide encoded by the polynucleotide set forth in (i); (iii) a polypeptide comprising, consisting or consisting essentially of a sequence encoding a nicotine N-demethylase and having at least 95% sequence identity to SEQ ID NO:3; or (iv) a construct, vector or expression vector comprising the isolated polynucleotide set forth in (i), and wherein the expression or activity of said nicotine demethylase is reduced as compared to a control tobacco plant cell in which the expression or activity of said nicotine demethylase has not been reduced.Type: GrantFiled: May 7, 2015Date of Patent: September 17, 2019Assignee: Philip Morris Products S.A.Inventors: Verena Liedschulte, Simon Goepfert, Lucien Bovet, Nicolas Sierro
-
Patent number: 10287599Abstract: The present invention relates to a mutant, non-naturally occurring or transgenic plant cell comprising: (i) at least one polynucleotide comprising, consisting or consisting essentially of a sequence encoding an isopropylmalate synthase and having at least 60% sequence identity to SEQ ID NO:1 or SEQ ID NO:10 or SEQ ID NO: 12 or SEQ ID NO:14; or (ii) a polypeptide encoded by said polynucleotide(s); or (iii) a polypeptide having at least 60% sequence identity to SEQ ID NO:2 or SEQ ID NO:11 or SEQ ID NO:13 or SEQ ID NO:15; or (iv) a construct, vector or expression vector comprising said polynucleotide sequence(s), optionally wherein said construct, vector or expression vector additionally comprises a promoter comprising, consisting or consisting essentially of the sequence set forth in SEQ ID NO:8 or a variant thereof with at least about 60% identity thereto or a trichome promoter.Type: GrantFiled: August 31, 2012Date of Patent: May 14, 2019Assignee: Philip Morris Products S.A.Inventors: Nicholas Bakaher, Gregor Nicholas Bindler, Michel Philippe Blanc, Simon Goepfert, Florian Martin
-
Publication number: 20170130239Abstract: The present invention relates to a mutant, non-naturally occurring or transgenic tobacco plant cell comprising: (i) a polynucleotide comprising, consisting or consisting essentially of a sequence encoding a functional nicotine N-demethylase and having at least 95% sequence identity to SEQ ID NO:2; (ii) a polypeptide encoded by the polynucleotide set forth in (i); (iii) a polypeptide comprising, consisting or consisting essentially of a sequence encoding a nicotine N-demethylase and having at least 95% sequence identity to SEQ ID NO:3; or (iv) a construct, vector or expression vector comprising the isolated polynucleotide set forth in (i), and wherein the expression or activity of said nicotine demethylase is reduced as compared to a control tobacco plant cell in which the expression or activity of said nicotine demethylase has not been reduced.Type: ApplicationFiled: May 7, 2015Publication date: May 11, 2017Inventors: Verena Liedschulte, Simon Goepfert, Lucien Bovet, Nicolas Sierro
-
Publication number: 20140352706Abstract: The present invention relates to a mutant, non-naturally occurring or transgenic plant cell comprising: (i) at least one polynucleotide comprising, consisting or consisting essentially of a sequence encoding an isopropylmalate synthase and having at least 60% sequence identity to SEQ ID NO:1 or SEQ ID NO:10 or SEQ ID NO: 12 or SEQ ID NO:14; or (ii) a polypeptide encoded by said polynucleotide(s); or (iii) a polypeptide having at least 60% sequence identity to SEQ ID NO:2 or SEQ ID NO:11 or SEQ ID NO:13 or SEQ ID NO:15; or (iv) a construct, vector or expression vector comprising said polynucleotide sequence(s), optionally wherein said construct, vector or expression vector additionally comprises a promoter comprising, consisting or consisting essentially of the sequence set forth in SEQ ID NO:8 or a variant thereof with at least about 60% identity thereto or a trichome promoter.Type: ApplicationFiled: August 31, 2012Publication date: December 4, 2014Applicant: PHILIP MORRIS PRODUCTS S.A.Inventors: Nicholas Bakaher, Gregor Nicholas Bindler, Michel Philippe Blanc, Simon Goepfert, Florian Martin